At Artiva, our mission is to deliver to cancer patients highly effective cellular immunotherapies that are also safe and immediately accessible. Towards this end, Artiva is advancing a pipeline of off-the-shelf, allogeneic NK cell therapies, including CAR-NK cell therapies, that leverage the company’s unique manufacturing and engineering capabilities. Artiva is headquartered in San Diego.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $198M
Founded date: 2019
Investors 5
| Date | Name | Website |
| 30.06.2020 | 5AM Ventur... | 5amventure... |
| 13.01.2022 | Medivate P... | medivatepa... |
| - | LINEA Inve... | lineainves... |
| - | RA Capital... | racap.com |
| - | EcoR1 Capi... | ecor1cap.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.03.2021 | Series B | $120M | - |
| 30.06.2020 | Series A | $78M | - |
Mentions in press and media 14
| Date | Title | Description | Source |
| 02.03.2021 | Artiva Biotherapeutics Raises $120M in Series B | SAN DIEGO, CA, Artiva Biotherapeutics, an oncology-focused biopharmaceutical company, announced th... | vcnewsdail... |
| 02.03.2021 | Artiva Biotherapeutics has raised a $120M Series B round led... | - | connect.or... |
| 01.03.2021 | Daily funding roundup - March 1st, 2021 | Skydio raised $170M; Artiva landed $120M; FogPharma secured $107M; Axonius picks up $100M Skydio: Sk... | vator.tv/n... |
| 01.03.2021 | Artiva Biotherapeutics Finds $120M In Series B | San Diego-based biopharmaceuticals company Artiva Biotherapeutics has raised a big, $120M funding ro... | socaltech.... |
| 26.02.2021 | Artiva, fresh from Merck pact, raises $120M for NK therapy R... | Artiva Biotherapeutics has raised $120 million to advance a pipeline of allogeneic natural killer (N... | fiercebiot... |
| 26.02.2021 | Artiva Biotherapeutics, Inc. announced that it has received ... | On February 26, 2021, Artiva Biotherapeutics, Inc. closed the transaction. The company raised fundin... | marketscre... |
| 26.02.2021 | Artiva Raises $120M in Series B Financing to Advance Pipelin... | - | 5amventure... |
| 26.02.2021 | Artiva Biotherapeutics Raises $120 Million in Series B Finan... | SAN DIEGO--(BUSINESS WIRE)--Feb 26, 2021-- Artiva Biotherapeutics, Inc., an oncology-focused biophar... | oaoa.com/n... |
| 26.02.2021 | Artiva, fresh from Merck pact, raises $120M for NK therapy R... | Artiva Biotherapeutics has raised $120 million to advance a pipeline of allogeneic natural killer (N... | fiercebiot... |
| 30.06.2020 | Artiva Biotherapeutics Closes $78M in Series A | SAN DIEGO, CA, Artiva Biotherapeutics announced that it has launched and closed $78 million in Ser... | vcnewsdail... |
Show more